Eurocor GmbH Product Pipeline Analysis

SUMMARY

Eurocor GmbH Product Pipeline Analysis

Summary

This report is an insightful source for data, analysis and strategic insights into a Eurocor GmbH's pipeline and investigational products. The report also provides details on clinical trials covering trial phase, description, investigator information, primary and secondary end-points and trial results for products in development.

Scope

• Details of development stage by sector and equipment type.
• Pipeline products grouped by therapy area, development stage and trial phase.
• Detailed information on clinical trials covering trial phase, description, investigator .nformation, primary and secondary end-points and trial results.
• Trial updates, trial start and end dates, patient numbers and the trials primary outcome measures, secondary outcome measures.
• Product updates covering estimated approval dates and estimated launch dates.
• Descriptions of novel technologies relating to pipeline products of the company.
• Patents and patent applications covered for the product.
• News updates on key events relating to the product and its development.

Reasons to buy

• A single source to fulfill competitor information relating to products in development.
• Identify pipeline products that are potential competitor to your product lines.
Understand a company's strategic position by accessing detailed independent intelligence on its product pipeline.
• Access clinical trial information to map trial results and plan targeted marketing activities.
• Take corrective measures on your own development programs and R&D initiatives based on regulatory events of competitor product pipelines.
• Identification of potential investment opportunities.
• Build up knowledge base for potential distribution and marketing partners.
• Helps avoid patent infringement.
• Timelines from concept to market lets you keep track of market potential build for a new product.
Assess a company's future growth by determining its pipeline depth, for probable acquisition opportunities.

TABLE OF CONTENTS

1 Table of Contents 3
1.1 List Of Tables 6
1.2 List of Figures 7
2 Company Overview 8
2.1 Key Information 8
2.2 Industry Outlook -- Cardiovascular Devices 8
3 Major Products and Services 9
3.1 Overview 9
4 Competitors 10
5 Locations And Subsidiaries 11
5.1 Head Office 11
5.2 Other Locations & Subsidiaries 11
6 Recent Developments 12
6.1 Product News 12
6.1.1 Dec 20, 2007: Opto Circuits Subsidiary Launches Dior; Will Tap Market Worth Us$1.20 Billion 12
6.1.2 Feb 20, 2007: Dior Recieves CE Certification 12
6.1.3 Jul 10, 2006: EuroCor Gets CE Approval For Taxcor-I DES 12
6.2 Product Approvals 12
6.2.1 Feb 20, 2007: Dior Recieves CE Certification 12
6.2.2 Jul 10, 2006: EuroCor Gets CE Approval For Taxcor-I DES 12
7 Eurocor GmbH Pipeline Products 13
7.1 Eurocor GmbH Product Pipeline Analysis 13
7.1.1 Eurocor GmbH Pipeline Products By Equipment Type 13
7.1.2 Eurocor GmbH Pipeline Products By Development Stage 14
7.1.3 Eurocor GmbH Pipeline Products By Therapy Area 15
7.1.4 Eurocor GmbH Pipeline Products By Clinical Trials 15
7.1.5 Eurocor GmbH Pipeline Products By News Summary 15
7.2 TAXCOR 16
7.2.1 Product Description 16
7.2.2 Product Status 16
7.2.3 Clinical Trials 16
7.2.4 Product Milestone 17
7.3 Genius MAGIC coronary stent system 17
7.3.1 Product Description 18
7.3.2 Product Status 18
7.4 Genius MEGAFLEX 18
7.4.1 Product Description 18
7.4.2 Product Status 18
7.4.3 Clinical Trials 18
7.5 Magic CC 19
7.5.1 Product Description 19
7.5.2 Product Status 19
7.5.3 Clinical Trials 19
7.6 RADIMAX Selfexpanding Nitinol Peripheral Stent System 20
7.6.1 Product Description 20
7.6.2 Product Status 20
7.7 JOKER Peripheral Balloon Catheter 20
7.7.1 Product Description 20
7.7.2 Product Status 21
7.8 FREEWAY Paclitaxel-Eluting Peripheral Balloon Catheter 21
7.8.1 Product Description 21
7.8.2 Product Status 21
7.9 Magico Stent 21
7.9.1 Product Description 22
7.9.2 Product Status 22
7.10 Drug coated renal stent 22
7.10.1 Product Description 22
7.10.2 Product Status 22
7.11 Genetic stent technology 22
7.11.1 Product Description 23
7.11.2 Product Status 23
7.12 RESORB 23
7.12.1 Product Description 23
7.12.2 Product Status 23
7.13 Minimally Invasive Neuroradiology Device 23
7.13.1 Product Description 24
7.13.2 Product Status 24
8 Appendix 25
8.1 Methodology 25
8.1.1 Coverage 25
8.1.2 Secondary Research 26
8.1.3 Primary Research 26
8.1.4 Expert Panel Validation 27
8.2 Contact Us 27
8.3 About Global Markets Direct 27
8.4 Disclaimer 27

1.1 List of Tables
Table 1: Eurocor GmbH,Key Facts 8
Table 2: Eurocor GmbH, Subsidiaries 11
Table 3: Eurocor GmbH Pipeline Products by Equipment Type 13
Table 4: Eurocor GmbH Pipeline Products By Development Stage 14
Table 5: Eurocor GmbH Pipeline Products By Therapy Area 15
Table 6: Eurocor GmbH Pipeline Products By Clinical Trials 15
Table 7: Eurocor GmbH Pipeline Products By News Summaries 15

1.2 List of Figures
Figure 1: Eurocor GmbH Pipeline Products By Development Stage 14
Figure 2: Global Markets Direct Methodology 25